Formoterol Fumarate Solution
Product Images NDC 50742-394

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Formoterol Fumarate (NDC 50742-394). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (20250313142244)

Flat packaging label for Formoterol Fumarate Inhalation Solution 20 mcg/2 mL vial from Ingenus Pharmaceuticals, LLC. The label includes product name, strength, dosage form, and intended route (oral inhalation), along with storage conditions, usage instructions, and manufacturer information. Dimensions and barcode placement are also indicated.*

FDA Label Image

1 (Image 1)

Chemical structure of the active ingredient Formoterol Fumarate, showing its molecular composition including aromatic rings, hydroxyl groups, amino groups, and a fumarate component with associated water of hydration.*

FDA Label Image

Figure 1 (Image 2)

A line graph comparing mean forced expiratory volume in 1 second (FEV1) in liters over a 12-hour period for Formoterol Fumarate Inhalation Solution 20 mcg and a placebo. The graph shows two plotted lines: one for the Formoterol Fumarate group and one for the placebo group, illustrating changes in mean FEV1 over time.*

FDA Label Image

Figure 2 (Image 3)

A line graph comparing mean FEV1 (in liters) over 12 hours between Formoterol Fumarate Inhalation Solution 20 mcg and placebo groups. The x-axis represents time in hours, and the y-axis shows mean FEV1 values. Two lines depict data for Formoterol Fumarate (higher values) and placebo (lower values), indicating changes over time.*

FDA Label Image

Picture 1 (Image 4)

An instructional diagram showing a hand holding an inhaler device poised over a nebulizer cup. The image depicts the step of adding medication solution to the nebulizer cup prior to assembly or use, relevant to Formoterol Fumarate respiratory inhalation solution.*

FDA Label Image

Picture 2 (Image 5)

An instructional illustration showing the assembly or preparation of a respiratory inhalation device. The image depicts a hand holding a T-shaped inhaler component with a separate part aligned for attachment or insertion. It appears to be a step in using or preparing the Formoterol Fumarate inhalation solution device.*

FDA Label Image

Picture 5 (Image 6)

Two-panel instructional illustration showing a person using a respiratory inhalation device. The left panel depicts the user placing the mouthpiece of the inhaler directly in their mouth. The right panel shows the user covering the mouthpiece with a face mask, preparing to inhale the medication. The device is held in one hand in both panels.*

FDA Label Image

30 Vials (Image 8)

Packaging label for Formoterol Fumarate Inhalation Solution 20 mcg/2 mL vial from Ingenus Pharmaceuticals, LLC. The product is a sterile oral unit dose solution for respiratory inhalation. The label includes storage conditions, usage instructions, NDC 50742-394-30, and a barcode. The carton contains 30 individually wrapped 2 mL vials.*

FDA Label Image

Ingenus Logo-1 (Image 9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.